Market Place
Sourcing Support
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Enforcement Report - Week of January 18, 2023
18 Jan 2023 //
FDA
Eisai: MHLW Grants ODD in Japan to Mecobalamin Ultrahigh-Dose Formulation
27 May 2022 //
ASIAONE
Drug industry cheers FSSAI’s removal of ban on methylcobalamin
30 Dec 2021 //
PHARMABIZ
Enforcement Report - Week of December 22, 2021
22 Dec 2021 //
FDA
Enforcement Report - Week of December 08, 2021
08 Dec 2021 //
FDA
Enforcement Report - Week of November 17, 2021
17 Nov 2021 //
FDA
Drug makers in bind due to FSSAI’s dubious stand on approval of methylcobalamin
16 Nov 2021 //
PHARMABIZ
Industry seeks intervention in notifying removal of ban on methylcobalamin
08 Nov 2021 //
PHARMABIZ
Centre as SDCs still implement arbitrary ban on methylcobalamin pan-India
29 Jun 2021 //
PHARMABIZ
FSSAI directs SDCs to take action on production of methylcobalamin
28 Sep 2020 //
PHARMABIZ
Industry approaches Centre to urgently notify for neurological disorders
17 Sep 2020 //
PHARMABIZ
FSSAI defined RDA values of methylcobalamin, vitamin C for drug nutraceuticals
09 Aug 2020 //
PHARMABIZ
FSSAI yet to notify methylcobalamin as nutraceutical ingredient for disorders
21 Jul 2020 //
PHARMABIZ
NPPA fixes retail prices of 21 formulations under DPCO 2013
10 Feb 2020 //
PHARMABIZ
NPPA fixes retail prices of 21 formulations under DPCO 2013
10 Feb 2020 //
PHARMABIZ
Ban on methylcobalamin to be revoked
23 Dec 2019 //
PHARMABIZ
CDSCO asks FSSAI to take action against manufacturers for sale methylcobalamin
11 Dec 2019 //
PHARMABIZ
Industry experts continue to contest ban on methylcobalamin in Gujarat
27 Nov 2019 //
PHARMABIZ
Industry experts contest FSSAI ban on methylcobalamin in Gujarat
19 Sep 2019 //
PHARMABIZ
Enforcement Report - Week of August 14, 2019
14 Aug 2019 //
FDA
Enforcement Report - Week of July 17, 2019
17 Jul 2019 //
FDA
Enforcement Report - Week of June 19, 2019
19 Jun 2019 //
FDA
Enforcement Report - Week of May 8, 2019
08 May 2019 //
FDA
NPPA fixes retail prices of 22 formulations under DPCO, 2013
06 May 2019 //
PHARMABIZ
Enforcement Report - Week of April 24, 2019
24 Apr 2019 //
FDA
Enforcement Report for Week of February 20, 2019
20 Feb 2019 //
FDA
Enforcement Report - Week of November 7, 2018
07 Nov 2018 //
FDA
Enforcement Report - Week of September 5, 2018
05 Sep 2018 //
FDA
Enforcement Report - Week of August 15, 2018
15 Aug 2018 //
FDA
Enforcement Report - Week of April 25, 2018
25 Apr 2018 //
FDA
Enforcement Report - Week of February 21, 2018
21 Feb 2018 //
FDA
Enforcement Report - Week of September 20, 2017
20 Sep 2017 //
FDA
Enforcement Report - Week of June 14, 2017
14 Jun 2017 //
FDA
Eisai withdraws NDA for mecobalamin ultra-high dose preparation as treatment for ALS
25 Mar 2016 //
CPHI ONLINE
Chen Shwezin recalls Methylcobalamin due to Lack of Assurance of Sterility
04 Nov 2015 //
FDA
